2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Endometrial Neoplasms
7
Lymphatic Metastasis
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
3
Breast Neoplasms
3
Thyroid Cancer, Papillary
2
Stomach Neoplasms
2
Prostatic Neoplasms
2
Postoperative Complications
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lymphedema
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Clinical Stage I Gastric Cancer AJCC v8
2
Carcinoma, Transitional Cell
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Urologic Neoplasms
1
Ureteral Neoplasms
1
Thyroid cancer, follicular
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Recurrence
1
Radiation Injuries
1
Prostate Adenocarcinoma
1
Platelet Glycoprotein IV Deficiency
1
Parotid Neoplasms
1
Interventions
Blood Specimen Collection
9
Surveys and Questionnaires
6
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Cyclophosphamide
6
Prednisone
5
Mammography
5
Colonoscopy
5
Biopsy
5
Positron Emission Tomography Computed Tomography
4
Magnetic Resonance Imaging
4
Lenalidomide
4
Biopsy, Fine-Needle
4
pembrolizumab
3
Tomography, X-Ray Computed
3
Surgical Procedures, Operative
3
Melphalan
3
Liquid Biopsy
3
Interviews as Topic
3
Exercise
3
Diagnostic Tests, Routine
3
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
3
weifuchun
2
obinutuzumab
2
fluciclovine F-18
2
daratumumab
2
carfilzomib
2
Urination
2
Preoperative Exercise
2
Positron-Emission Tomography
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
Lymph Node Excision
×
Clear all
NCT02951897
2016-11-02
CTCs detection
Third Military Medical University
Phase NA
Unknown
120 enrolled